Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15591037rdf:typepubmed:Citationlld:pubmed
pubmed-article:15591037lifeskim:mentionsumls-concept:C1123019lld:lifeskim
pubmed-article:15591037lifeskim:mentionsumls-concept:C0018207lld:lifeskim
pubmed-article:15591037lifeskim:mentionsumls-concept:C0262950lld:lifeskim
pubmed-article:15591037lifeskim:mentionsumls-concept:C0441472lld:lifeskim
pubmed-article:15591037lifeskim:mentionsumls-concept:C1853126lld:lifeskim
pubmed-article:15591037lifeskim:mentionsumls-concept:C1325896lld:lifeskim
pubmed-article:15591037lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:15591037pubmed:issue3lld:pubmed
pubmed-article:15591037pubmed:dateCreated2004-12-13lld:pubmed
pubmed-article:15591037pubmed:abstractTextWe have recently reported that bone morphogenetic protein-4 (BMP-4) can inhibit progesterone production by ovine granulosa cells (GCs). Here, we have investigated the underlying mechanisms of this effect in basal as well as in FSH-induced conditions. We have confirmed that treatment with BMP-4 decreased basal GC progesterone secretion and totally abolished FSH-stimulating action. This inhibitory action was associated with a decrease in the expression of cAMP-regulated genes, steroidogenic acute regulatory protein (StAR) and P450 side-chain cleavage (P450 scc) at mRNA and protein levels. However, BMP-4 did not alter basal cAMP production by GCs. In contrast, BMP-4 decreased by half the FSH-induced cAMP production and strongly inhibited cAMP-induced progesterone production. Thus, the inhibitory effect of BMP-4 was exerted both upstream and downstream of cAMP signalling. We next examined the downstream effect, focusing on cAMP-dependent transcription factors, steroidogenic factor-1 (SF-1) and CREB, through the BMP factor signalling intermediary, Smad1. As expected, BMP-4 induced phosphorylation and transcriptional activity of Smad1 in ovine GCs. BMP-4-activated Smad1 did not affect CREB activity but inhibited the transcriptional activity of SF-1 on the canonical SF-1 responsive element. Interestingly, this transcriptional inhibitory mechanism occurred on transfected StAR and P450 scc promoter. Based on these results, we propose that SF-1 is a key target in the inhibitory mechanism exerted by BMP-4 on progesterone synthesis by ovine GCs in culture. Because SF-1 plays an essential role in the differentiation of GCs, our findings could have new implications in understanding the role of BMP family members in the control of ovarian folliculogenesis.lld:pubmed
pubmed-article:15591037pubmed:languageenglld:pubmed
pubmed-article:15591037pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15591037pubmed:citationSubsetIMlld:pubmed
pubmed-article:15591037pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15591037pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15591037pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15591037pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15591037pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15591037pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15591037pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15591037pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15591037pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15591037pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15591037pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15591037pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15591037pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15591037pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15591037pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15591037pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15591037pubmed:statusMEDLINElld:pubmed
pubmed-article:15591037pubmed:monthDeclld:pubmed
pubmed-article:15591037pubmed:issn0952-5041lld:pubmed
pubmed-article:15591037pubmed:authorpubmed-author:DupontJJlld:pubmed
pubmed-article:15591037pubmed:authorpubmed-author:PisseletCClld:pubmed
pubmed-article:15591037pubmed:authorpubmed-author:FabreSSlld:pubmed
pubmed-article:15591037pubmed:authorpubmed-author:MongetPPlld:pubmed
pubmed-article:15591037pubmed:authorpubmed-author:MonniauxDDlld:pubmed
pubmed-article:15591037pubmed:authorpubmed-author:PierreAAlld:pubmed
pubmed-article:15591037pubmed:authorpubmed-author:Mandon-PépinB...lld:pubmed
pubmed-article:15591037pubmed:issnTypePrintlld:pubmed
pubmed-article:15591037pubmed:volume33lld:pubmed
pubmed-article:15591037pubmed:ownerNLMlld:pubmed
pubmed-article:15591037pubmed:authorsCompleteYlld:pubmed
pubmed-article:15591037pubmed:pagination805-17lld:pubmed
pubmed-article:15591037pubmed:dateRevised2009-8-12lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:meshHeadingpubmed-meshheading:15591037...lld:pubmed
pubmed-article:15591037pubmed:year2004lld:pubmed
pubmed-article:15591037pubmed:articleTitleMolecular basis of bone morphogenetic protein-4 inhibitory action on progesterone secretion by ovine granulosa cells.lld:pubmed
pubmed-article:15591037pubmed:affiliationPhysiologie de la Reproduction et des Comportements, UMR 6175 INRA-CNRS-Université de Tours, Haras Nationaux, 37380 Nouzilly, France.lld:pubmed
pubmed-article:15591037pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15591037pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:652entrezgene:pubmedpubmed-article:15591037lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15591037lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15591037lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15591037lld:pubmed